Free Trial

ADMA Biologics (ADMA) Insider Trading & Ownership

→ Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad)
Free ADMA Stock Alerts
$6.44
-0.02 (-0.31%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.00%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$579,800.00
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$13.80 M
Get ADMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADMA Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADMA Insider Buying and Selling by Quarter

Ad Wall Street Star
AI finds its first serious application
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

ADMA Biologics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Steve ElmsDirectorSell49,887$6.01$299,820.87  
3/15/2024Steve ElmsDirectorSell183,008$6.01$1,099,878.08  
3/13/2024Steve ElmsDirectorSell407,000$6.21$2,527,470.00  
8/30/2023Jerrold B GrossmanDirectorBuy130,000$3.71$482,300.00  
8/24/2023Young KwonDirectorBuy25,000$3.90$97,500.00  
8/22/2023Bryant FongDirectorSell1,433,304$3.87$5,546,886.48  
8/18/2023Adam S GrossmanCEOSell250,000$4.15$1,037,500.00  
8/15/2023Adam S GrossmanCEOSell510,469$4.54$2,317,529.26  
8/15/2023Brian LenzCFOSell211,578$4.60$973,258.80  
(Data available from 1/1/2013 forward)

ADMA Insider Trading Activity - Frequently Asked Questions

Who is on ADMA Biologics's Insider Roster?

The list of insiders at ADMA Biologics includes Adam S Grossman, Brian Lenz, Bryant Fong, Jerrold B Grossman, Perceptive Advisors Llc, Steve Elms, and Young Kwon. Learn more on insiders at ADMA.

What percentage of ADMA Biologics stock is owned by insiders?

6.00% of ADMA Biologics stock is owned by insiders. Learn more on ADMA's insider holdings.

Which ADMA Biologics insiders have been buying company stock?

The following insiders have purchased ADMA shares in the last 24 months: Adam S Grossman ($42,851.38), Brian Lenz ($19,999.98), Jerrold B Grossman ($482,300.00), and Young Kwon ($97,500.00).

How much insider buying is happening at ADMA Biologics?

Insiders have purchased a total of 176,976 ADMA shares in the last 24 months for a total of $642,651.36 bought.

Which ADMA Biologics insiders have been selling company stock?

The following insiders have sold ADMA shares in the last 24 months: Adam S Grossman ($3,355,029.26), Brian Lenz ($973,258.80), Bryant Fong ($5,546,886.48), and Steve Elms ($3,927,168.95).

How much insider selling is happening at ADMA Biologics?

Insiders have sold a total of 3,045,246 ADMA Biologics shares in the last 24 months for a total of $13,802,343.49 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ADMA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press